COST-EFFECTIVENESS OF EARLY TREATMENT OF ACPA POSITIVE RHEUMATOID ARTHRITIS PATIENTS WITH ABATACEPT

被引：0
|
作者：
Neubauer, A. S. [1 ]
Minartz, C. [1 ]
Herrmann, K. H. [2 ]
Postema, R. [3 ]
Baerwald, C. [4 ]
机构：
[1] IfGPh, Inst Hlth Econ IfG, Munich, Germany
[2] Bristol Myers Squibb, Munich, Germany
[3] Bristol Myers Squibb, London, England
[4] Univ Leipzig, Rheumatol Unit, Leipzig, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0626
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept
    Neubauer, A. S.
    Minartz, C.
    Herrmann, K. H.
    Baerwald, C. G. O.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : 448 - 454
  • [2] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [3] A COST-EFFECTIVENESS ASSESSMENT OF ABATACEPT FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN HUNGARY
    Brodszky, V
    Borgstrom, F.
    Arnetorp, S.
    Pentek, M.
    Gulacsi, L.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A549 - A550
  • [4] COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA
    Alfonso-Cristancho, R.
    Aiello, E. C.
    Roa, C. N.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [5] COST-EFFECTIVENESS OF ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN CHILE
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A223
  • [6] Trial-based cost-effectiveness of abatacept for rheumatoid arthritis patients in Italy
    Gaultney, J.
    Benucci, M.
    Iannazzo, S.
    Nappi, C.
    Sion, K.
    Sabater, F. J.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (03) : 409 - 417
  • [7] Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis
    Tsao, Nicole W.
    Shojania, Kam
    Marra, Carlo A.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (01) : 9 - 18
  • [8] ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS
    Alfonso-Cristancho, R.
    Serra, N.
    Aiello, E. C.
    Roa, C. N.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A126 - A127
  • [9] Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
    Harrold, Leslie R.
    Wittstock, Keith
    Kelly, Sheila
    Han, Xue
    Zhuo, Joe
    Schrader, Amy
    Middaugh, Nicole
    Moore, Page C.
    Khaychuk, Vadim
    [J]. ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [10] Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
    Leslie R. Harrold
    Keith Wittstock
    Sheila Kelly
    Xue Han
    Joe Zhuo
    Amy Schrader
    Nicole Middaugh
    Page C. Moore
    Vadim Khaychuk
    [J]. Advances in Rheumatology, 64
12345